Clinical Trials Logo
  1. Home
  2. Pulmonary Diseases
  3. NCT00367913

Clarithromycin v Ciprofloxacin Added to Rifampicin + Ethambutol, for Opportunist Mycobacterial Pulmonary Disease

Pulmonary Diseases Clinical Trial

Official title:
Treatment of Pulmonary Disease Caused by MAIS, M.Xenopi or M.Malmoense: A Comparison of Two Triple Drug Regimens and an Assessment of the Value of Immunotherapy With M.Vaccae

Clinical Trial Summary

To date key drugs in the treatment of MAIS, M.malmoense and M.xenopi (Opportunist Mycobacteria have been rifampicin and ethambutol. Clarithromycin and Ciprofloxacin are active in vitro against these species of mycobacteria. The primary aim of this study was to compare these to agents as supplements to rifampicin and ethambutol. A secondary aim was to assess the vale of immunotherapy with M.vaccae.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00367913
Study type Interventional
Source British Thoracic Society
Contact
Status Completed
Phase Phase 4
Start date March 1995
Completion date September 2004
View Details
See also
  Status Clinical Trial Phase
Completed NCT02146235 - Music Therapy in the Treatment of Chronic Obstructive Pulmonary Disease N/A
Not yet recruiting NCT05452148 - Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid Organ Transplant Recipients: Potential Involvement of Mycophenolic Acid
Not yet recruiting NCT05847894 - Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
Completed NCT00719784 - Vibration Response Imaging in the Diagnosis of Pulmonary Disease N/A
Completed NCT03740646 - Pneumocystis Primary Infection in Non-immunosuppressed Infants
Completed NCT00284141 - Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma Phase 2
Completed NCT00293514 - TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM) Phase 3
Completed NCT02002351 - Prospective Study on Rehabilitation Patients With Pulmonary Hypertension and Other Pulmonary Diseases N/A
Recruiting NCT01592513 - Effect of BIS Monitoring on Propofol Usage During Elective Bronchoscopy N/A
Completed NCT00886353 - Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2) Phase 1
Completed NCT00320151 - Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases N/A
Completed NCT00395330 - Airways Dysfunction Following WTC Dust Exposure N/A
Not yet recruiting NCT00248391 - The Influence of Feeding Position on Pulmonary Morbidity in Young Children N/A